Preliminary recommendations for lung surgery during 2019 novel coronavirus disease (Covid-19) epidemic period

Chinese Journal of Lung Cancer

Volumn 23, Issue 3, 2020, Pages 133-135

  Li, Xin ^a   Liu, Ming Hui ^a   Zhao, Qing Chun ^a   Liu, Ren Wang ^a   Zhang, Hong Bing ^a   Dong, Ming ^a   Xu, Song ^a   Zhao, Hong Lin ^a   Wei, Sen ^a   Song, Zuo Qing ^a   Chen, Gang ^a   Chen, Jun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

2019 novel coronavirus disease (COVID 19); Lung occupying lesions; Surgical treatment

Indexed keywords

ARTICLE; CHINA; CORONAVIRUS DISEASE 2019; EPIDEMIC; HUMAN; KNOWLEDGE; LUNG LESION; LUNG SURGERY; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; THORACIC SURGEON; BETACORONAVIRUS; CORONAVIRUS INFECTION; EPIDEMIOLOGY; LUNG DISEASE; PATHOGENICITY; PATIENT CARE PLANNING; THORAX SURGERY; VIRUS PNEUMONIA;

COVID-19; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;

BETACORONAVIRUS; CHINA; CORONAVIRUS INFECTIONS; EPIDEMICS; HUMANS; LUNG DISEASES; PATIENT CARE PLANNING; PNEUMONIA, VIRAL; THORACIC SURGICAL PROCEDURES;

EID: 85079740917     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2020.03.01     Document Type: Article

References (4)

1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395(10223): 507-513. doi: 10.1016/S0140-6736(20)30211-7
2. Robbins HA, Katki HA, Cheung LC, et al. Insights for management of ground-glass opacities from the National Lung Screening Trial. J Thorac Oncol, 2019, 14(9): 1662-1665. doi: 10.1016/j.jtho.2019.05.012
3. Hammer MM, Palazzo LL, Kong CY, et al. Cancer risk in subsolid nodules in the National Lung Screening Trial. Radiology, 2019, 293(2): 441-448. doi: 10.1148/radiol.2019190905
4. Liang WH, Guan WJ, Chen RC, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol, 2020. doi: 10.1016/S1470-2045(20)30096-6